Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigen

Immunotherapy has shown limited success in prostate cancer; this may be partially explained by its immunosuppressive tumor microenvironment (TME). Although androgen-deprivation therapy (ADT), the most common treatment for prostate cancer, initially promotes a robust T cell infiltrate, T cell respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez-Bujanda, Zoila A., Chaimowitz, Matthew G., Armstrong, Todd D., Foote, Jeremy B., Emens, Leisha A., Drake, Charles G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781773/
https://www.ncbi.nlm.nih.gov/pubmed/33457094
http://dx.doi.org/10.1080/2162402X.2020.1809926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781773/
https://www.ncbi.nlm.nih.gov/pubmed/33457094
http://dx.doi.org/10.1080/2162402X.2020.1809926

Ejemplares similares